ELOXX PHARMACEUTICALS, INC. Derivative Liability, Noncurrent
ELOXX PHARMACEUTICALS, INC. (ELOX) had Derivative Liability, Noncurrent of $0 as of 2017-09-30, per its 10-Q filed 2017-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2017-11-14
- 2017-09-30: Derivative Liability, Noncurrent $0.00.
- 2017-06-30: Derivative Liability, Noncurrent $1.84M; Derivative Liability, Noncurrent as first filed $0.00.
- 2017-03-31: Derivative Liability, Noncurrent $0.00.
- 2016-12-31: Derivative Liability, Noncurrent $0.00.
| Period end | Derivative Liability, Noncurrent | Derivative Liability, Noncurrent as first filed |
|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $1.84M 10-Q · filed 2017-11-14 | $0.00 10-K · filed 2017-10-13 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-22 | |
| 2016-12-31 | $0.00 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $319.55K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $956.58K 10-K · filed 2017-10-13 | |
| 2016-03-31 | $920.60K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $2.33M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $2.23M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $2.50M 10-K · filed 2017-10-13 | |
| 2014-06-30 | $0.00 10-K · filed 2016-10-13 | |
| 2013-06-30 | $0.00 10-K · filed 2013-09-11 | |
| 2013-03-31 | $261.76K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $30.30K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $94.74K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $238.80K 10-K · filed 2013-09-11 | |
| 2012-03-31 | $402.90K 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $478.94K 10-Q · filed 2013-02-14 | $478.95K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $439.56K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $711.26K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |